Breadcrumb

What's New at the RI-MUHC ?

The MUHC teams up with LSU Health New Orleans to advance Usher Syndrome antisense therapy research

Researchers collaborate to treat vision loss linked to Usher thanks to a 1.74 million USD grant from the National Institutes of Health

Safe and efficient tool to reduce seniors’ medication overload

The elderly are often prescribed multiple medications for different health conditions. While some medications are needed, polypharmacy and medication overload can be costly and even harmful.

New cutting-edge cardiac MRI machine at the Glen site is a boon to patients and heart research!

The MUHC received the 3T GE SIGNA™ Premier, a flagship GE Medical Systems Cardiac Magnetic Resonance (MR) machine, on Saturday, September 21, 2019

Sepsis: testing before starting treatment is essential

Timely administration of appropriate antibiotics is essential to prevent death in patients with severe infections. Can healthcare teams “skip” drawing blood for bacterial cultures?

A close look at the progression of cells from normal to tumour

How exactly does a normal cell become a tumour?

How Salmonella tackles cellular defense mechanisms

Researchers uncover new protein that plays key role in bacterial infections

Strong criteria for diagnosing sarcopenia

Scientists propose diagnostic tools to identify, and possibly limit, the effects of sarcopenia, a disease that significantly reduces the quality of life of the aging population

Move to single-patient rooms at MUHC’s Glen site resulted in immediate, dramatic and long-lasting decrease of infection rates

Rates of colonization of two health-associated infections tumbled soon after historic hospital move

Montréal sans HépC: a fight to eliminate HCV in Montreal

Marina Klein co-leads initiative to make Montreal the first city in North America to eliminate hepatitis C

What is safe sedation in the ICU?

Dr. Yoanna Skrobik is co-author of an editorial in the New England Journal of Medicine

Learn more about the RI-MUHC